Fig. 1
Unreasonable omission of evidence-based medications over 12 months. ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, B beta-blockers
Fig. 1 | The Egyptian Heart Journal
Unreasonable omission of evidence-based medications over 12 months. ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, B beta-blockers